Skip to main content
Arvee Laboratories (India) Limited logo

Arvee Laboratories (India) Limited — Investor Relations & Filings

Ticker · ARVEE ISIN · INE006Z01016 LEI · 33580075Q2EAWYCO4C50 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2022-08-23 Regulatory Filings
Country IN India
Listing National Stock Exchange of India ARVEE

About Arvee Laboratories (India) Limited

http://arveelabs.com/

Arvee Laboratories (India) Limited specializes in the manufacturing and export of specialty chemicals and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds, including Dimethyl 5-Sulfoisophthalate Sodium Salt (DMSIP), 5-Sulfoisophthalic Acid Monosodium Salt, and various other aromatic intermediates. These products serve as critical components in the textile, polymer, and pharmaceutical sectors. Arvee Laboratories emphasizes research and development to enhance its chemical synthesis processes and maintain international quality standards. Its operations involve complex chemical reactions such as sulfonation, esterification, and reduction, catering to a diverse global clientele requiring specialized chemical solutions for industrial applications.

Recent filings

Filing Released Lang Actions
General updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 53 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2022-08-23 English
Annual General Meeting
Regulatory Filings
2022-08-05 English
General updates
Regulatory Filings
2022-08-04 English
Outcome of Board Meeting
Regulatory Filings
2022-08-02 English
Board Meeting — Financial results/Other business matters
Regulatory Filings Classification · 100% confidence The document text is extremely short (69 characters) and contains no substantive content, financial data, or any report-related information. It only includes a placeholder for an omitted picture and no text that could indicate the nature of the filing. Given the lack of content, this document cannot be classified as a report or announcement of a report. It fits best as a Regulatory Filing (RNS) which is the fallback category for miscellaneous filings without specific content.
2022-07-20 English
Book Closure
Notice of Dividend Amount Classification · 95% confidence The document contains information about a corporate action related to a dividend, including book closure dates and a meeting date (AGM). It specifies dividend details and dates but does not contain financial statements or detailed report content. The document is short (722 characters) and appears to be an announcement of dividend-related corporate action rather than a full report. Therefore, it fits best under the category of Notice of Dividend Amount (DIV).
2022-07-14 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.